Marrone Bio Innovations Inc (MBII) Hits New 52-week Low During January 14 Session

Equities Staff |

Marrone Bio Innovations Inc (MBII) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.85, Marrone Bio Innovations Inc dropped to $0.65 for a new 52-week low. By the closing bell, the company's stock was at $0.75 a share for a loss of 11.76%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

Marrone Bio Innovations Inc saw 28,666 shares of its stock trade hands, that's out of 24.46 million shares outstand. The stock has an average daily volume of 36,668 shares. After hitting a new 52-week low, Marrone Bio Innovations Inc enters the new trading day with a market cap of 18.35 million, a 50-day SMA of $1.64 and a 200-day SMA of $2.26

For a complete fundamental analysis analysis of Marrone Bio Innovations Inc, check out’s Stock Valuation Analysis report for MBII. To see the latest independent stock recommendations from’s analysts, visit our Research section.

Marrone Bio Innovations Inc is a producer of bio-based pest management and plant health products. The Company offers its products to the markets that use conventional chemical pesticides, including certain agricultural and water markets.

Marrone Bio Innovations Inc has 86 employees, is led by CEO Pamela G. Marrone, and makes its home in Davis, CA.

Marrone Bio Innovations Inc is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets

Dropbox, Inc.

Dropbox is a service that allows their users to bring all photos, docs, and videos anywhere, and share them easily. Any file saved to Dropbox will automatically save to all…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…